Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine is an urgent global health priority. This study evaluated the effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Roques, Pierre, Fritzer, Andrea, Dereuddre-Bosquet, Nathalie, Wressnigg, Nina, Hochreiter, Romana, Bossevot, Laetitia, Pascal, Quentin, Guehenneux, Fabienne, Bitzer, Annegret, Corbic Ramljak, Irena, Le Grand, Roger, Lundberg, Urban, Meinke, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431671/
https://www.ncbi.nlm.nih.gov/pubmed/35700051
http://dx.doi.org/10.1172/jci.insight.160173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431671/
https://www.ncbi.nlm.nih.gov/pubmed/35700051
http://dx.doi.org/10.1172/jci.insight.160173

Ejemplares similares